Michael Gutkin, MD
Physical Medicine & Rehabilitation · Hackettstown, NJNPI 1083695258
Payments from drug & device makers
Across 61 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$448
- Abbott$235
- Collegium Pharmaceutical, Inc.$42
- Amgen$41
- Pfizer$35
- Saluda Medical Americas, Inc.$35
- plus $121 from 5 others
What the payments were for
- Food & beverage$956100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $448 |
| Abbott | 12 | $235 |
| Collegium Pharmaceutical, Inc. | 3 | $42 |
| Amgen | 3 | $41 |
| Pfizer | 3 | $35 |
| Saluda Medical Americas, Inc. | 3 | $35 |
| Nevro Corp. | 1 | $33 |
| Bioventus LLC | 1 | $29 |
| Daiichi Sankyo Inc. | 2 | $25 |
| Nalu Medical, Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
How this compares
$956 in reported general payments places this provider in the 75th percentile of 434 physical medicine & rehabilitation providers in New Jersey.
See all physical medicine & rehabilitation providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 32 | $24,795 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 208 | $5,545 |
| Hysingla ErHydrocodone Bitartrate | 12 | $4,266 |
| Gabapentin | 219 | $3,286 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 84 | $2,668 |
| Morphine Sulfate ErMorphine Sulfate | 66 | $2,271 |
| Cyclobenzaprine Hcl | 60 | $854 |
| Tizanidine Hcl | 84 | $743 |
| Celecoxib | 42 | $602 |
| Oxycodone Hcl | 26 | $471 |
| Morphine Sulfate | 17 | $461 |
| Pregabalin | 25 | $449 |
| Tramadol Hcl | 49 | $431 |
| Meloxicam | 95 | $334 |
| Methocarbamol | 33 | $316 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Hackettstown
- Scott WoskaTinton Falls$2M
- Brian KimToms River$459K
- Steven EscaldiEdison$74K
- Yekyung KongWest Orange$61K
- Michael VerdeToms River$54K
- Joseph IbrahimBayonne$52K
- Steven KirshblumWest Orange$51K
- Brian GreenwaldEdison$39K
- Joseph ValenzaChester$29K
- Christine GreissEdison$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.